AlloSource has announced the release of AlloFuse Select CM, a premium addition to the company’s AlloFuse portfolio.
AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to initiate and nurture bone growth, delivering the benefits of autograft bone without the potential drawbacks.
The product is clinically proven to activate and support bone formation, and can be used in a variety of spinal, neurologic, and orthopaedic procedures.
This cellular allograft matrix is intended to exhibit good handling characteristics, as it is mouldable and compressible for insertion into interbody implants or placement around anatomical structures.
